UTHSC In the Media


In the Media

Dr. Michael Whitt Discusses Ebola

In the Media Icon

Michael Whitt, PhD, professor and interim chair of the Department of Microbiology, Immunology and Biochemistry, discussed ebola.


In the Media

Dr. Pfeffer Interviewed about Daily Aspirin

My Fox Memphis

Dr. Lawrence Pfeffer from the UT Health Science Center is here with more.


In the Media

UTHSC’s Growing Presence on the Pharmaceutical Stage

In the Media Icon

With the University of Tennessee Health Science Center preparing to build a state-of-the-art pharmaceutical manufacturing facility on campus it’s easy to see why the university’s executive vice chancellor and chief operations officer has such an abiding interest in pharmaceutical safety.


In the Media

UTHSC Recruits for Diabetes Study

In the Media Icon

UTHSC is now recruiting participants for the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study.


In the Media

UTHSC Studying Best Way to Manage Diabetes

In the Media Icon

The University of Tennessee Health Science Center (UTHSC) has been selected to join 36 other centers to conduct the GRADE Study.


In the Media

Dr. Dagogo-Jack Contributes Column on Diabetes

In the Media Icon

Scientists from the CDC have defined a geographical area, known as the “Diabetes Belt,” where residents are more likely to have type 2 diabetes.


In the Media

On the Move: Joan Han

The Memphis Business Journal

Joan Han joins the University of Tennessee Health Science Centera as associate professor in the Department of Pediatrics, Division of Endocrinology, and founding director of the new UT-Le Bonheur Pediatric Obesity Center. Dr. Han will also be director of the Pediatric Obesity Program on Le Bonheur’s clinical staff.  


In the Media

Dr. Nair Treats Hepatitis C Patients with New Drug Sovaldi

The Daily News

Satheesh Nair, MD, professor of medicine at the University of Tennessee Health Science Center and medical director of Transplant Hepatology at Methodist University Hospital, says that he and his partner have treated about 200 patients with the drug since its release in December and the results have been astonishing.